How fat molecules in blood affect liver cancer radiotherapy
Part of Cancer, Digestive system clinical trials.
This study looks at whether certain fats in your blood can help predict how well radiotherapy works for liver cancer. If you are getting radiation for liver cancer, your blood samples may help doctors learn more about your treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with primary liver cancer (cancer that started in your liver).
- Your doctor has decided that you need radiation therapy as part of your treatment.
- You are expected to live at least 3 months or more.
- You do not have other types of cancer or severe health conditions like uncontrolled diabetes, serious heart or lung problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people having liver cancer surgery. It will look at certain fats in your blood to see if they can help doctors understand and track liver cancer better.
This study looks at a simple blood test to help predict how well your tumor will respond to radiation therapy. By measuring a protein called CHI3L1 in your blood before and during treatment, the study aims to help doctors personalize your care.
This study looks at a blood test (biomarker) to see how well people with hepatitis B-related liver cancer respond to radiation therapy and what their long-term outlook may be. It aims to find better ways to predict treatment outcomes.
This trial studies how radiation therapy affects the immune system and outcomes in people with liver cancer. It may help doctors understand better ways to treat the disease.
This trial is for people with liver cancer (hepatocellular carcinoma) who are about to receive a type of internal radiation therapy called TARE (also known as radioembolization). Researchers want to learn more about how the cancer responds to this treatment using scans and biopsies. You might be a good fit if you have not had any prior treatment for your liver cancer.
This trial tests a combination of liver-directed radiation therapy, an immunotherapy drug (which helps your immune system fight cancer), and a drug that blocks blood vessel growth to the tumor. It is for people with advanced liver cancer that cannot be treated with surgery.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.